On ECHEMI
Home > Drugs > Beijing Honglin Pharmaceutical Co., Ltd.
Beijing Honglin Pharmaceutical Co., Ltd.
  • Founded in:

    1993-12-07
  • Country:

    China China
  • Address:

    Yanqi Industrial Development Zone, Huairou District, Beijing
  • Tax NO.:

    91110000621702873B
  • Registered Funds:

    $15.8 million
  • Website:

  • Email:

Related Drugs
Loratadine Sustained-Release Tablets
This product is a compound preparation, its components are: acetaminophen, pseudoephedrine sulfate, and loratadine.
Name Description Content CAS NO. Registered Holders
Acetaminophen

Oral acetanilide antipyretic analgesic may produce antipyretic and analgesic effects mainly by inhibiting the synthesis of prostaglandins

More

Oral acetanilide antipyretic analgesic may produce antipyretic and analgesic effects mainly by inhibiting the synthesis of prostaglandins

103-90-2 68
Loratadine

Long-acting tricyclic antihistamines that selectively antagonize peripheral H1 receptors to relieve nasal or non-nasal symptoms of seasonal allergic rhinitis

More

Long-acting tricyclic antihistamines that selectively antagonize peripheral H1 receptors to relieve nasal or non-nasal symptoms of seasonal allergic rhinitis

79794-75-5 61
Pseudoephedrine sulfate

Adrenaline-mimetic drugs can constrict the blood vessels of the nasal mucosa and relieve symptoms of nasal congestion and runny nose

More

Adrenaline-mimetic drugs can constrict the blood vessels of the nasal mucosa and relieve symptoms of nasal congestion and runny nose

0
Famotidine Calcium Magnesium Chewable Tablets
Main ingredients: This product is a compound preparation, which consists of 10 mg of famotidine, 800 mg of calcium carbonate and 165 mg of magnesium hydroxide.
Name Description Content CAS NO. Registered Holders
Famotidine

Histamine H2 receptor antagonist, which has an inhibitory effect on the secretion of gastric acid and pepsin and can reduce the production of gastric acid

More

Histamine H2 receptor antagonist, which has an inhibitory effect on the secretion of gastric acid and pepsin and can reduce the production of gastric acid

10mg 76824-35-6 69
Calcium carbonate

Antacids, which neutralize stomach acid that has already been produced

More

Antacids, which neutralize stomach acid that has already been produced

800mg 471-34-1 43
Magnesium hydroxide

Antacids, which neutralize stomach acid that has already been produced

More

Antacids, which neutralize stomach acid that has already been produced

165mg 1309-42-8 20
Amlodipine Besylate Tablets
The chemical name of this product is: 3-ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate benzenesulfonate
Name Description Content CAS NO. Registered Holders
Amlodipine

Calcium blockers (also known as slow channel blockers or calcium antagonists) block the entry of calcium ions across the membrane into myocardial and vascular smooth muscle cells.

More

Calcium blockers (also known as slow channel blockers or calcium antagonists) block the entry of calcium ions across the membrane into myocardial and vascular smooth muscle cells.

88150-42-9 2
Lansoprazole enteric-coated capsules
The main ingredient of this product is lansoprazole. Its chemical name is (plusmn;)-2[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole.
Name Description Content CAS NO. Registered Holders
Lansoprazole

Under acidic conditions, it transforms into an active structure and combines with the SH group of the proton pump ((HK)-ATPase), inhibiting the activity of the enzyme and thus inhibiting gastric acid secretion; it can inhibit the (HK)-ATPase activity of microsomes in dog gastric mucosa; it has an inhibitory effect on the acid secretion of dog gastric mucosal parietal cells stimulated by histamine, acetylcholine and gastrin; it significantly inhibits the acid secretion, nocturnal gastric acid secretion and 24-hour gastric acid secretion caused by gastrin or insulin in healthy adults; it promotes the healing of chronic gastric and duodenal ulcers in rats; it inhibits gastric ulcers caused by water immersion stress test, aspirin or ethanol, as well as duodenal ulcers and reflux esophagitis caused by mepirisol or hemi-photoamine in rats.

More

Under acidic conditions, it transforms into an active structure and combines with the SH group of the proton pump ((HK)-ATPase), inhibiting the activity of the enzyme and thus inhibiting gastric acid secretion; it can inhibit the (HK)-ATPase activity of microsomes in dog gastric mucosa; it has an inhibitory effect on the acid secretion of dog gastric mucosal parietal cells stimulated by histamine, acetylcholine and gastrin; it significantly inhibits the acid secretion, nocturnal gastric acid secretion and 24-hour gastric acid secretion caused by gastrin or insulin in healthy adults; it promotes the healing of chronic gastric and duodenal ulcers in rats; it inhibits gastric ulcers caused by water immersion stress test, aspirin or ethanol, as well as duodenal ulcers and reflux esophagitis caused by mepirisol or hemi-photoamine in rats.

103577-45-3 88
Nifedipine sustained-release tablets (Ⅲ)
Chemical name: 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylic acid dimethyl ester Molecular weight: C17H18N2O6
Name Description Content CAS NO. Registered Holders
Nifedipine

Dihydropyridine calcium antagonists selectively inhibit the transmembrane transport of calcium ions into myocardial cells and smooth muscle cells, dilate coronary arteries and peripheral resistance vessels, and reduce myocardial oxygen consumption and cardiac load. They have no carcinogenic or mutagenic effects, but high doses may affect reproduction and embryonic development.

More

Dihydropyridine calcium antagonists selectively inhibit the transmembrane transport of calcium ions into myocardial cells and smooth muscle cells, dilate coronary arteries and peripheral resistance vessels, and reduce myocardial oxygen consumption and cardiac load. They have no carcinogenic or mutagenic effects, but high doses may affect reproduction and embryonic development.

21829-25-4 74
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.